These 4 Indian Pharma Stocks will give good return between Tariff Trade War | Paisa Live


If your portfolio has Pharma stocks, then these news is very important for coming because there may be many big announcements. Us President Donald Trump is not taking the name of the Tariff. Trump applied 26% tariff rate on India but kept the Pharma Sector untouched but 8 April the Donald Trump itself announced the installation of tariffs on Pharmaceutical Companies and since which has been a tension in Pharma Companies. This tariff will affect both India and US countries. Indian pharma manufacturers earn from 30% to 50% from American Market. Let us talk about India’s 4 Indian Pharmaceutical Firms, whose stocks can be on high risk due to the tariff. So Dr Reddy’s Laboratories, Aurobindo Pharma, Zydus Lifescienes and Sun Pharma. Will it be right to buy these stocks during this Trade War, watch the video to know.



Source link

support@headlinenews360.com

Related Posts

Big news related to 8th Pay Commission! How to benefit CGHS, know everything here

8th Pay Commission CGHS: The central government announced the formation of the 8th Pay Commission in January 2025. The main task of this commission is to recommend amendment in salaries…

UK lawmakers approve rescue of British Steel in emergency parliamentary session – Times of India

In a rare emergency session on Saturday, UK lawmakers cut short their Easter break to pass legislation rescuing the country’s last fully integrated steel plant from imminent closure.Prime Minister Keir…

Leave a Reply

Your email address will not be published. Required fields are marked *